Published in J Virol on July 01, 1991
The UL11 gene of herpes simplex virus 1 encodes a function that facilitates nucleocapsid envelopment and egress from cells. J Virol (1992) 2.58
Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol (1999) 2.09
Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J (1995) 2.05
Hepatitis B virus morphogenesis. World J Gastroenterol (2007) 1.92
A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J Virol (1997) 1.78
Mapping a region of the large envelope protein required for hepatitis B virion maturation. J Virol (1994) 1.73
Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol (1995) 1.54
Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J Virol (2007) 1.16
Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J Virol (1992) 1.01
Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells. J Virol (1994) 0.98
Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein. J Virol (2001) 0.97
Determination of the minimal distance between the matrix and transmembrane domains of the large hepatitis B virus envelope protein. J Virol (2005) 0.87
Characterization of human and rat brain myristoyl-CoA:protein N-myristoyltransferase: evidence for an alternative splice variant of the enzyme. Biochem J (1998) 0.82
An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation. J Virol (2015) 0.77
Posttranslational modifications and secretion efficiency of immunogenic hepatitis B virus L protein deletion variants. Virol J (2013) 0.75
Vaccines Targeting PreS1 Domain Overcome Immune Tolerance in HBV Carrier Mice. Hepatology (2017) 0.75
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
The hepatitis B virus. Nature (1985) 8.71
Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol (1989) 8.22
Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J (1990) 7.03
Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol (1984) 6.90
The biology and enzymology of eukaryotic protein acylation. Annu Rev Biochem (1988) 6.83
Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell (1986) 5.35
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell (1989) 3.60
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol (1988) 3.21
Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol (1987) 3.16
Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science (1986) 3.01
Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol Cell Biol (1984) 2.98
Specific and saturable binding of pp60v-src to plasma membranes: evidence for a myristyl-src receptor. Cell (1989) 2.53
The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. J Virol (1987) 2.49
Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci U S A (1986) 2.28
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24
Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol Cell Biol (1989) 2.05
Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature (1987) 1.98
Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor. J Cell Biol (1988) 1.91
The src protein contains multiple domains for specific attachment to membranes. Mol Cell Biol (1990) 1.90
Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. J Virol (1990) 1.72
Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol (1987) 1.64
Heat shock and the sorting of luminal ER proteins. EMBO J (1989) 1.54
Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol (1990) 1.41
Distinctive properties of the hepatitis B virus envelope proteins. J Virol (1988) 1.32
Myristylated polyomavirus VP2: role in the life cycle of the virus. J Virol (1990) 1.17
Hepatitis B polypeptide vaccine preparation in micelle form. Nature (1981) 1.12
Fatty acid acylation of vaccinia virus proteins. J Virol (1989) 1.03
Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells. J Mol Biol (1987) 0.98
Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles. J Virol (1988) 0.91
An expression vector for high-level protein synthesis in Vero cells. Gene (1989) 0.91
Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors. Gene (1989) 0.87
Cell-type dependent expression and secretion of hepatitis B virus pre-S1 surface antigen. Postgrad Med J (1987) 0.86
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Nucleotide sequence and expression of the diphtheria tox228 gene in Escherichia coli. Science (1983) 2.65
Generation and neutralization of pseudovirions of human papillomavirus type 33. J Virol (1997) 2.29
Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol (1986) 2.20
Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J (1995) 2.05
Nucleotide sequence of a cluster of early and late genes in a conserved segment of the vaccinia virus genome. Nucleic Acids Res (1985) 2.02
Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A (1984) 2.00
Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology (1994) 1.89
Patchwork structure of a bovine satellite DNA. Cell (1979) 1.77
Defined fragments of calf, human, and rat DNA produced by restriction nucleases. Eur J Biochem (1974) 1.73
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 1.70
Single-strand and double-strand cleavage at half-modified and fully modified recognition sites for the restriction nucleases Sau3a and Taqi. Gene (1980) 1.63
Closely spaced nucleosome cores in reconstituted histone.DNA complexes and histone-H1-depleted chromatin. Eur J Biochem (1978) 1.62
Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J Virol (1998) 1.52
Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J Gen Virol (1995) 1.48
Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol (1993) 1.45
Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol (1994) 1.44
The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens. J Virol (1986) 1.41
Immunological analyses of human papillomavirus capsids. Vaccine (2001) 1.40
Diphtheria toxin promoter function in Corynebacterium diphtheriae and Escherichia coli. Nucleic Acids Res (1985) 1.38
A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science (1986) 1.30
A long-range and two short-range periodicities are superimposed in the 1.706-g/cm3 satellite DNA from calf thymus. Eur J Biochem (1978) 1.25
Mapping of cleavage sites for restriction endonucleases in lambdadv plasmids. Eur J Biochem (1975) 1.23
Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology (1995) 1.21
Cleavage of small bacteriophage and plasmid DNAs by restriction endonucleases. Eur J Biochem (1974) 1.16
Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33. J Virol (1993) 1.11
Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2. J Gen Virol (1995) 1.11
Phosphorylation of dephosphorylated tRNA and oligonucleotides by polynucleotide kinase. Biochim Biophys Acta (1970) 1.09
Genome organization and nucleotide sequence of human papillomavirus type 39. Virology (1991) 1.07
Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J Virol (1992) 1.01
Chromatin diminution in Ascaris suum: nucleotide sequence of the eliminated satellite DNA. Nucleic Acids Res (1982) 1.00
Investigation of the repetitive sequences in calf DNA by cleavage with restriction nucleases. Eur J Biochem (1975) 1.00
Nucleosome formation abolishes base-specific binding of histones. Nature (1975) 1.00
Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33. Virology (2001) 1.00
Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells. J Mol Biol (1987) 0.98
Prototype sequence of bovine 1.720 satellite DNA. J Mol Biol (1980) 0.97
Inserted sequences in bovine satellite DNA's. Science (1981) 0.96
A multicopy insertion sequence in the bovine genome with structural homology to the long terminal repeats of retroviruses. Nature (1982) 0.94
Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch Virol (1997) 0.92
Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles. J Virol (1988) 0.91
Enhancement of gene expression by somatic hybridization with primary cells: high-level synthesis of the hepatitis B surface antigen in monkey Vero cells by fusion with primary hepatocytes. Biotechnology (N Y) (1990) 0.91
An expression vector for high-level protein synthesis in Vero cells. Gene (1989) 0.91
Characterization of the native and denatured conformations of tRNA Ser and tRNA Phe from yeast. Eur J Biochem (1972) 0.90
Synthesis, properties and applications of papillomavirus-like particles. Intervirology (1996) 0.85
Reconstituted histone--DNA complexes. Philos Trans R Soc Lond B Biol Sci (1978) 0.83
Isolation of cis-acting vaccinia virus DNA fragments promoting the expression of herpes simplex virus thymidine kinase by recombinant viruses. J Virol (1985) 0.83
The location of inhibitory specificities in human mucus proteinase inhibitor (MPI): separate expression of the COOH-terminal domain yields an active inhibitor of three different proteinases. Protein Eng (1990) 0.82
Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes. J Gen Virol (1995) 0.81
An alternative procedure for the strand separation of DNA fragments. FEBS Lett (1981) 0.80
Amplifiable expression vectors for mammalian cell lines. Gene (1987) 0.80
Human papillomavirus type 42: new sequences, conserved genome organization. Virology (1992) 0.78
Deletion and insertion mutants of HBsAg particles. Arch Virol Suppl (1992) 0.78
Expression of the hepatitis B virus large envelope protein in Saccharomyces cerevisiae. Gene (1986) 0.77
A transformed Vero cell line stably producing the hepatitis B virus surface antigen. Gene (1984) 0.77
Expression of immunogenically reactive diphtheria toxin fusion proteins under the control of the pR promoter of bacteriophage lambda. Gene (1986) 0.77
Physical map of PM2 DNA. Hoppe Seylers Z Physiol Chem (1979) 0.77
Construction and characterization of hybrid hepatitis B antigen particles carrying a poliovirus immunogen. Biochimie (1988) 0.76
Mutational analysis of HBsAg assembly. Intervirology (1995) 0.75
[Synthesis and recombination of DNA from eukaryotic and prokaryotic cells]. Fortschr Med (1977) 0.75
Conformational states of transfer ribonucleic acids. Basic Life Sci (1973) 0.75
[A new approach for explaining viral organotropism: fusion of HBV transfected cells with hepatocytes]. Z Gastroenterol Verh (1990) 0.75
Identification of vaccinia promoters by heterologous expression of hepatitis B surface antigen in mouse cells infected by recombinant vaccinia viruses. Biochim Biophys Acta (1987) 0.75